Alcohol use disorders are common in developed countries, where alcohol is cheap, readily
available, and heavily promoted. Common, mild disorders often remit in young adulthood …

ABSTRACT BACKGROUND Alcohol dependence results in multiple hospital readmissions,
but no discharge planning protocol has been studied to improve outcomes. The inpatient …

Background Today, it is proved that isoenzymes CYP2D6 and CYP3A4 are involved in
metabolism of haloperidol. In our previous investigation, we found a medium correlation …

Background: Haloperidol is used for the treatment of alcohol use disorders in patients with
signs of alcohol-related psychosis. Haloperidol therapy poses a high risk of adverse drug …

Management of alcohol withdrawal in critically ill patients is a challenge. The alcohol
consumption histories of intensive care patients are often incomplete, limiting identification …

Background Antipsychotic action of haloperidol is due to blockade of D2 receptors in the
mesolimbic dopamine pathway, while the adverse drug reactions are associated with striatal …

Background Isoenzymes CYP2D6 and CYP3A4, the activity of which varies widely, are
involved in metabolism of haloperidol and may influence its profile of efficacy and safety …

Background People with opioid use disorder experience high burden of disease from
medical comorbidities and are increasingly hospitalized with medical complications …

Introduction We previously reported that benzodiazepine detoxification for alcohol
withdrawal using symptom-triggered therapy (STT) with oral diazepam reduced length of …

Objectives: We sought to examine alcohol use disorder (AUD) among general hospital
medical inpatients with respect to identification, service utilization, and initiation of …